~~<i id='D6C05C71CF'><strike id='D6C05C71CF'><tt id='D6C05C71CF'><pre id='D6C05C71CF'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

Wikipedia

author：entertainment 2025-09-30 20:34:53 - browse：9

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： U.K. sequencing study surfaces new findings about tumor DNA

explore

entertainment

explore

hotspot

knowledge

CarstenSnejbjerg/BloombergLONDON—TheinvestmentarmofNovoNordisk’sparentfoundationisbuyingdrugmanufact

WSS

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

Cano Health’s bankruptcy is a warning for Medicare Advantage

Why CTE doesn’t keep Americans from enjoying the Super Bowl

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

Unique patient identifier: Experts argue the benefits, pitfalls

U.K. sequencing study surfaces new findings about tumor DNA

knowledge

Wikipedia

explore

Hepatitis C has a cure — but many Americans still lack access to it

J&J to buy cancer drug developer Ambrx Biopharma

At least 13 dead in Texas as scorching temps continue

Padmanee Sharma of MD Anderson at center of lawsuit over credit

Sports medicine is finally prioritizing gender equality

JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

Hepatitis C has a cure — but many Americans still lack access to it

Padmanee Sharma of MD Anderson at center of lawsuit over credit

ChatGPT in medicine: STAT answers readers' burning questions

Devoted Health’s losses in Medicare Advantage persist

explore

UCB departs biotech trade group BIO

Ahead of JPM, here's who's profiting most in health care

Burning questions for the 2024 JPM Healthcare Conference

Updated Covid vaccine has 54% effectiveness, new study suggests

Why psychiatrists like me stop taking insurance

Why Novartis is going to walk from its acquisition of MorphoSys

entertainment

explore

hotspot

knowledge